Cooper DA - Search Results

1

Buffalo hump seen in HIV-associated lipodystrophy is associated with hyperinsulinemia but not dyslipidemia.

Mallon PW, Wand H, Law M, Miller J, Cooper DA, Carr A; HIV Lipodystrophy Case Definition Study; Australian Lipodystrophy Prevalence Survey Investigators. Mallon PW, et al. Among authors: cooper da. J Acquir Immune Defic Syndr. 2005 Feb 1;38(2):156-62. doi: 10.1097/01.qai.0000147527.64863.1a. J Acquir Immune Defic Syndr. 2005. PMID: 15671800

2

Centralized assessment of dual-energy X-ray absorptiometry (DEXA) in multicenter studies of HIV-associated lipodystrophy.

Smith DE, Hudson J, Martin A, Freund J, Griffiths MR, Kalnins S, Law M, Carr A, Cooper DA; PIILR DEXA Group and Investigators. Smith DE, et al. Among authors: cooper da. HIV Clin Trials. 2003 Jan-Feb;4(1):45-9. doi: 10.1310/WRL8-DWH1-7VQL-AK81. HIV Clin Trials. 2003. PMID: 12577196 Clinical Trial.

3

HIV-associated lipodystrophy: description, pathogenesis, and molecular pathways.

Mallon PW, Carr A, Cooper DA. Mallon PW, et al. Among authors: cooper da. Curr Diab Rep. 2002 Apr;2(2):116-24. doi: 10.1007/s11892-002-0070-x. Curr Diab Rep. 2002. PMID: 12643131 Review.

4

Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapy.

Mallon PW, Miller J, Cooper DA, Carr A. Mallon PW, et al. Among authors: cooper da. AIDS. 2003 May 2;17(7):971-9. doi: 10.1097/00002030-200305020-00005. AIDS. 2003. PMID: 12700446

5

Methodological considerations in human studies of gene expression in HIV-associated lipodystrophy.

Mallon PW, Sedwell R, Unemori P, Kelleher A, Cooper DA, Carr A. Mallon PW, et al. Among authors: cooper da. Antivir Ther. 2005;10 Suppl 2:M101-8. Antivir Ther. 2005. PMID: 16152711 Review.

6

Evaluation of the HIV lipodystrophy case definition in a placebo-controlled, 144-week study in antiretroviral-naive adults.

Law M, Puls R, Cheng AK, Cooper DA, Carr A. Law M, et al. Among authors: cooper da. Antivir Ther. 2006;11(2):179-86. Antivir Ther. 2006. PMID: 16640099 Clinical Trial.

7

Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial.

Carr A, Workman C, Smith DE, Hoy J, Hudson J, Doong N, Martin A, Amin J, Freund J, Law M, Cooper DA; Mitochondrial Toxicity (MITOX) Study Group. Carr A, et al. Among authors: cooper da. JAMA. 2002 Jul 10;288(2):207-15. doi: 10.1001/jama.288.2.207. JAMA. 2002. PMID: 12095385 Clinical Trial.

8

Altered myocellular and abdominal fat partitioning predict disturbance in insulin action in HIV protease inhibitor-related lipodystrophy.

Gan SK, Samaras K, Thompson CH, Kraegen EW, Carr A, Cooper DA, Chisholm DJ. Gan SK, et al. Among authors: cooper da. Diabetes. 2002 Nov;51(11):3163-9. doi: 10.2337/diabetes.51.11.3163. Diabetes. 2002. PMID: 12401706

9

Thymidine analogue withdrawal for lipoatrophic patients on protease-sparing therapy improves lipoatrophy but compromises antiviral control: the PIILR extension study.

Smith DE, Carr A, Law M, Martin A, Hudson J, Hoy J, Cooper DA. Smith DE, et al. Among authors: cooper da. AIDS. 2002 Dec 6;16(18):2489-91. doi: 10.1097/00002030-200212060-00020. AIDS. 2002. PMID: 12461429 Clinical Trial. No abstract available.

10

Effect of therapeutic drug monitoring on outcome in antiretroviral experienced HIV-infected individuals.

Mallon PW, Ray J, Cooper DA. Mallon PW, et al. Among authors: cooper da. J Clin Virol. 2003 Feb;26(2):223-7. doi: 10.1016/s1386-6532(02)00120-8. J Clin Virol. 2003. PMID: 12600653

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

828 results

Search Page

Filters